Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - levocabastine hydrochloride, quantity: 0.54 mg/ml (equivalent: levocabastine, qty 0.5 mg/ml) - spray, nasal - excipient ingredients: disodium edetate; polysorbate 80; hypromellose; monobasic sodium phosphate; purified water; propylene glycol; benzalkonium chloride; dibasic sodium phosphate - symptomatic treatment of seasonal or perennial allergic rhinitis.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - levocabastine hydrochloride, quantity: 0.54 mg/ml (equivalent: levocabastine, qty 0.5 mg/ml) - eye drops, suspension - excipient ingredients: hypromellose; disodium edetate; benzalkonium chloride; polysorbate 80; propylene glycol; dibasic sodium phosphate; monobasic sodium phosphate; water for injections - symptomatic treatment of seasonal allergic conjunctivitis.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - cetirizine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; macrogol 400 - for use in the treatment of seasonal allergic rhinitis in adults & children 12 years of age or older.

Арменија - Енглески - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

aesica pharmaceuticals s.r.l. - cetirizine (cetirizine dihydrochloride) - drops oral - 10mg/ml

Арменија - Енглески - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

aesica pharmaceuticals s.r.l. - cetirizine (cetirizine dihydrochloride) - tablets film-coated - 10mg

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - cetirizine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - seasonal allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing and redness of the eyes. perennial allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. chronic idiopathic urticaria: cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 1-12 years. it significantly reduces the occurrence, severity and duration of hives and markedly reduces pruritus. as with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - cetirizine hydrochloride, quantity: 1 mg/ml - oral liquid - excipient ingredients: sodium acetate; saccharin sodium; glacial acetic acid; propylene glycol; sorbitol solution (70 per cent) (non-crystallising); propyl hydroxybenzoate; glycerol; purified water; methyl hydroxybenzoate; flavour - seasonal allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing and redness of the eyes. perennial allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. chronic idiopathic urticaria: cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 1-12 years. it significantly reduces the occurence, severity and duration of hives and markedly reduces pruritus. as with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - cetirizine hydrochloride, quantity: 10 mg/ml - oral liquid - excipient ingredients: propyl hydroxybenzoate; sodium acetate; glycerol; saccharin sodium; propylene glycol; glacial acetic acid; methyl hydroxybenzoate; purified water - seasonal allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with seasonal allergic rhinitis (hay fever) in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, orcular pruritus and tearing and redness of the eyes. perennial allergic rhinitis: cetirizine is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children aged 1-12 years. symptoms treated effectively include sneezing, rhinorrhoea, post-nasal discharge, nasal pruritus, ocular pruritus and tearing. chronic idiopathic urticaria: cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 1-12 years. it significantly reduces the occurence, severity and duration of hives and markedly reduces pruritus. as with other antihistamines, patients should be advised to seek medical advice about the possibility that their urticaria is associated with ingestion of certain foods.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - excipient ingredients: - symptomatic relief of seasonal or perennial allergic rhinitis symptomatic relief for urticaria (tablets)

Арменија - Енглески - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

aesica pharmaceuticals s.r.l. - cetirizine (cetirizine dihydrochloride) - tablets film-coated - 10mg